Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)
China flag China · Delayed Price · Currency is CNY
19.68
+0.09 (0.46%)
Nov 17, 2026, 3:00 PM CST

SHA:600332 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
2,1652,9832,8354,0563,9673,720
Depreciation & Amortization
865.94865.94875.24929.44743.83676.99
Other Amortization
89.9189.9160.9655.8849.8343.53
Loss (Gain) From Sale of Assets
-107.74-107.74-11.12-12.03-0.69-0.69
Asset Writedown & Restructuring Costs
3.923.922.93-0.427.063.08
Loss (Gain) From Sale of Investments
-416.45-416.4539.18-288.71-417.58-390.47
Provision & Write-off of Bad Debts
102.09102.0958.8173.5354.5595.1
Other Operating Activities
3,566556.97608.18660.47715.79659.84
Change in Accounts Receivable
-2,542-2,542-255.91-417.27-1,992-1,627
Change in Inventory
-351.71-351.71-1,314-835.03-242.22-673.65
Change in Accounts Payable
-1,474-1,474602.7-66.124,1213,158
Operating Cash Flow
1,958-232.463,4424,1046,9995,673
Operating Cash Flow Growth
-11.89%--16.11%-41.37%23.36%869.52%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,085-1,240-1,128-1,628-1,384-1,255
Sale of Property, Plant & Equipment
200.34120.332.3613.931.496.61
Cash Acquisitions
-387.32.26-1.57-147.67-1.39
Divestitures
-0.98-0.98---32.57
Investment in Securities
-3,931-3,380-5,053-1,885-6,23342.79
Other Investing Activities
582.82490.7216.09384.46214.82242.77
Investing Cash Flow
-4,621-4,007-5,964-3,115-7,253-931.57

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-299.98-299.96599.91-
Long-Term Debt Issued
-12,6859,9549,6049,6968,826
Total Debt Issued
17,32812,9859,9549,90410,2968,826
Short-Term Debt Repaid
----900--
Long-Term Debt Repaid
--11,387-8,648-9,646-8,422-8,943
Lease Payments
-255.93-255.93-257.4-268.39-271.66-285.66
Total Debt Repaid
-14,801-11,387-8,648-10,546-8,422-8,943
Net Debt Issued (Repaid)
2,5271,5981,306-642.151,874-116.76
Common Dividends Paid
-1,706-1,648-2,251-1,585-1,491-1,266
Other Financing Activities
578.57539.04-61.59249.35-337.16-111.17
Financing Cash Flow
1,400489.35-1,006-1,97845.95-1,494

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-10.683.857.148.08-0.50.28
Net Cash Flow
-1,274-3,747-3,521-981.16-208.673,248

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
872.45-1,4722,3142,4755,6154,419
Free Cash Flow Growth
-12.44%--6.50%-55.92%27.08%-
Free Cash Flow Margin
1.12%-1.90%3.09%3.28%7.93%6.40%
Free Cash Flow Per Share
0.54-0.911.421.523.452.72
Levered Free Cash Flow
-7,359-2,421838.991,1693,9471,963
Unlevered Free Cash Flow
-7,100-2,1701,1001,4484,2192,224
Free Cash Flow After Leases
616.53-1,7282,0572,2075,3444,133

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
2,8872,8222,7293,1402,7592,873
Change in Working Capital
-4,317-4,317-1,028-1,3721,879860.49